Click for best price
LongTerm Asthma Drugs Market Size, Share 2023
The global Long-Term Asthma Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Tablet Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Long-Term Asthma Drugs include Pfizer, GlaxoSmithKline, Novartis, Merck, Boehringer Ingelheim, AstraZeneca, Roche, Teva Pharmaceutical and Vectura Group, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Long-Term Asthma Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long-Term Asthma Drugs. This report contains market size and forecasts of Long-Term Asthma Drugs in global, including the following market information:
- Global Long-Term Asthma Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
- Global top five companies in 2022 (%)
We surveyed the Long-Term Asthma Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Long-Term Asthma Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Long-Term Asthma Drugs Market Segment Percentages, by Type, 2022 (%)
Global Long-Term Asthma Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Long-Term Asthma Drugs Market Segment Percentages, by Application, 2022 (%)
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Global Long-Term Asthma Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Long-Term Asthma Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Long-Term Asthma Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Long-Term Asthma Drugs revenues share in global market, 2022 (%)
key players include:
- Pfizer
- GlaxoSmithKline
- Novartis
- Merck
- Boehringer Ingelheim
- AstraZeneca
- Roche
- Teva Pharmaceutical
- Vectura Group
Outline of Major Chapters:
Chapter 1: Introduces the definition of Long-Term Asthma Drugs, market overview.
Chapter 2: Global Long-Term Asthma Drugs market size in revenue.
Chapter 3: Detailed analysis of Long-Term Asthma Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Long-Term Asthma Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Long-Term Asthma Drugs Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
67 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Long-Term Asthma Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Long-Term Asthma Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Long-Term Asthma Drugs Overall Market Size
2.1 Global Long-Term Asthma Drugs Market Size: 2022 VS 2029
2.2 Global Long-Term Asthma Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Long-Term Asthma Drugs Players in Global Market
3.2 Top Global Long-Term Asthma Drugs Companies Ranked by Revenue
3.3 Global Long-Term Asthma Drugs Revenue by Companies
3.4 Top 3 and Top 5 Long-Term Asthma Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Long-Term Asthma Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Long-Term Asthma Drugs Players in Global Market
3.6.1 List of Global Tier 1 Long-Term Asthma Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Long-Term Asthma Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Long-Term Asthma Drugs Market Size Markets, 2022 & 2029
4.1.2 Tablet
4.1.3 Spray
4.2 By Type - Global Long-Term Asthma Drugs Revenue & Forecasts
4.2.1 By Type - Global Long-Term Asthma Drugs Revenue, 2018-2023
4.2.2 By Type - Global Long-Term Asthma Drugs Revenue, 2024-2029
4.2.3 By Type - Global Long-Term Asthma Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Long-Term Asthma Drugs Market Size, 2022 & 2029
5.1.2 Hospital Pharmacy
5.1.3 Online Pharmacy
5.1.4 Retail Pharmacy
5.2 By Application - Global Long-Term Asthma Drugs Revenue & Forecasts
5.2.1 By Application - Global Long-Term Asthma Drugs Revenue, 2018-2023
5.2.2 By Application - Global Long-Term Asthma Drugs Revenue, 2024-2029
5.2.3 By Application - Global Long-Term Asthma Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Long-Term Asthma Drugs Market Size, 2022 & 2029
6.2 By Region - Global Long-Term Asthma Drugs Revenue & Forecasts
6.2.1 By Region - Global Long-Term Asthma Drugs Revenue, 2018-2023
6.2.2 By Region - Global Long-Term Asthma Drugs Revenue, 2024-2029
6.2.3 By Region - Global Long-Term Asthma Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Long-Term Asthma Drugs Revenue, 2018-2029
6.3.2 US Long-Term Asthma Drugs Market Size, 2018-2029
6.3.3 Canada Long-Term Asthma Drugs Market Size, 2018-2029
6.3.4 Mexico Long-Term Asthma Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Long-Term Asthma Drugs Revenue, 2018-2029
6.4.2 Germany Long-Term Asthma Drugs Market Size, 2018-2029
6.4.3 France Long-Term Asthma Drugs Market Size, 2018-2029
6.4.4 U.K. Long-Term Asthma Drugs Market Size, 2018-2029
6.4.5 Italy Long-Term Asthma Drugs Market Size, 2018-2029
6.4.6 Russia Long-Term Asthma Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Long-Term Asthma Drugs Market Size, 2018-2029
6.4.8 Benelux Long-Term Asthma Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Long-Term Asthma Drugs Revenue, 2018-2029
6.5.2 China Long-Term Asthma Drugs Market Size, 2018-2029
6.5.3 Japan Long-Term Asthma Drugs Market Size, 2018-2029
6.5.4 South Korea Long-Term Asthma Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Long-Term Asthma Drugs Market Size, 2018-2029
6.5.6 India Long-Term Asthma Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Long-Term Asthma Drugs Revenue, 2018-2029
6.6.2 Brazil Long-Term Asthma Drugs Market Size, 2018-2029
6.6.3 Argentina Long-Term Asthma Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Long-Term Asthma Drugs Revenue, 2018-2029
6.7.2 Turkey Long-Term Asthma Drugs Market Size, 2018-2029
6.7.3 Israel Long-Term Asthma Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Long-Term Asthma Drugs Market Size, 2018-2029
6.7.5 UAE Long-Term Asthma Drugs Market Size, 2018-2029
7 Long-Term Asthma Drugs Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Long-Term Asthma Drugs Major Product Offerings
7.1.4 Pfizer Long-Term Asthma Drugs Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Company Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Long-Term Asthma Drugs Major Product Offerings
7.2.4 GlaxoSmithKline Long-Term Asthma Drugs Revenue in Global Market (2018-2023)
7.2.5 GlaxoSmithKline Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Long-Term Asthma Drugs Major Product Offerings
7.3.4 Novartis Long-Term Asthma Drugs Revenue in Global Market (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Long-Term Asthma Drugs Major Product Offerings
7.4.4 Merck Long-Term Asthma Drugs Revenue in Global Market (2018-2023)
7.4.5 Merck Key News & Latest Developments
7.5 Boehringer Ingelheim
7.5.1 Boehringer Ingelheim Company Summary
7.5.2 Boehringer Ingelheim Business Overview
7.5.3 Boehringer Ingelheim Long-Term Asthma Drugs Major Product Offerings
7.5.4 Boehringer Ingelheim Long-Term Asthma Drugs Revenue in Global Market (2018-2023)
7.5.5 Boehringer Ingelheim Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Long-Term Asthma Drugs Major Product Offerings
7.6.4 AstraZeneca Long-Term Asthma Drugs Revenue in Global Market (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Roche
7.7.1 Roche Company Summary
7.7.2 Roche Business Overview
7.7.3 Roche Long-Term Asthma Drugs Major Product Offerings
7.7.4 Roche Long-Term Asthma Drugs Revenue in Global Market (2018-2023)
7.7.5 Roche Key News & Latest Developments
7.8 Teva Pharmaceutical
7.8.1 Teva Pharmaceutical Company Summary
7.8.2 Teva Pharmaceutical Business Overview
7.8.3 Teva Pharmaceutical Long-Term Asthma Drugs Major Product Offerings
7.8.4 Teva Pharmaceutical Long-Term Asthma Drugs Revenue in Global Market (2018-2023)
7.8.5 Teva Pharmaceutical Key News & Latest Developments
7.9 Vectura Group
7.9.1 Vectura Group Company Summary
7.9.2 Vectura Group Business Overview
7.9.3 Vectura Group Long-Term Asthma Drugs Major Product Offerings
7.9.4 Vectura Group Long-Term Asthma Drugs Revenue in Global Market (2018-2023)
7.9.5 Vectura Group Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Long-Term Asthma Drugs Market Opportunities & Trends in Global Market
Table 2. Long-Term Asthma Drugs Market Drivers in Global Market
Table 3. Long-Term Asthma Drugs Market Restraints in Global Market
Table 4. Key Players of Long-Term Asthma Drugs in Global Market
Table 5. Top Long-Term Asthma Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Long-Term Asthma Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Long-Term Asthma Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Long-Term Asthma Drugs Product Type
Table 9. List of Global Tier 1 Long-Term Asthma Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Long-Term Asthma Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Long-Term Asthma Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Long-Term Asthma Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Long-Term Asthma Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Long-Term Asthma Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Long-Term Asthma Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Long-Term Asthma Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Long-Term Asthma Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Long-Term Asthma Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Long-Term Asthma Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Long-Term Asthma Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Long-Term Asthma Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Long-Term Asthma Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Long-Term Asthma Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Long-Term Asthma Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Long-Term Asthma Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Long-Term Asthma Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Long-Term Asthma Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Long-Term Asthma Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Long-Term Asthma Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer Company Summary
Table 31. Pfizer Long-Term Asthma Drugs Product Offerings
Table 32. Pfizer Long-Term Asthma Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. GlaxoSmithKline Company Summary
Table 35. GlaxoSmithKline Long-Term Asthma Drugs Product Offerings
Table 36. GlaxoSmithKline Long-Term Asthma Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. GlaxoSmithKline Key News & Latest Developments
Table 38. Novartis Company Summary
Table 39. Novartis Long-Term Asthma Drugs Product Offerings
Table 40. Novartis Long-Term Asthma Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Novartis Key News & Latest Developments
Table 42. Merck Company Summary
Table 43. Merck Long-Term Asthma Drugs Product Offerings
Table 44. Merck Long-Term Asthma Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Merck Key News & Latest Developments
Table 46. Boehringer Ingelheim Company Summary
Table 47. Boehringer Ingelheim Long-Term Asthma Drugs Product Offerings
Table 48. Boehringer Ingelheim Long-Term Asthma Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Boehringer Ingelheim Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Long-Term Asthma Drugs Product Offerings
Table 52. AstraZeneca Long-Term Asthma Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Roche Company Summary
Table 55. Roche Long-Term Asthma Drugs Product Offerings
Table 56. Roche Long-Term Asthma Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Roche Key News & Latest Developments
Table 58. Teva Pharmaceutical Company Summary
Table 59. Teva Pharmaceutical Long-Term Asthma Drugs Product Offerings
Table 60. Teva Pharmaceutical Long-Term Asthma Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Teva Pharmaceutical Key News & Latest Developments
Table 62. Vectura Group Company Summary
Table 63. Vectura Group Long-Term Asthma Drugs Product Offerings
Table 64. Vectura Group Long-Term Asthma Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Vectura Group Key News & Latest Developments
List of Figures
Figure 1. Long-Term Asthma Drugs Segment by Type in 2022
Figure 2. Long-Term Asthma Drugs Segment by Application in 2022
Figure 3. Global Long-Term Asthma Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Long-Term Asthma Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Long-Term Asthma Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Long-Term Asthma Drugs Revenue in 2022
Figure 8. By Type - Global Long-Term Asthma Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Long-Term Asthma Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Long-Term Asthma Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Long-Term Asthma Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Long-Term Asthma Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Long-Term Asthma Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Long-Term Asthma Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Long-Term Asthma Drugs Revenue Market Share, 2018-2029
Figure 16. US Long-Term Asthma Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Long-Term Asthma Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Long-Term Asthma Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Long-Term Asthma Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Long-Term Asthma Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Long-Term Asthma Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Long-Term Asthma Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Long-Term Asthma Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Long-Term Asthma Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Long-Term Asthma Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Long-Term Asthma Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Long-Term Asthma Drugs Revenue Market Share, 2018-2029
Figure 28. China Long-Term Asthma Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Long-Term Asthma Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Long-Term Asthma Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Long-Term Asthma Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Long-Term Asthma Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Long-Term Asthma Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Long-Term Asthma Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Long-Term Asthma Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Long-Term Asthma Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Long-Term Asthma Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Long-Term Asthma Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Long-Term Asthma Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Long-Term Asthma Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer Long-Term Asthma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. GlaxoSmithKline Long-Term Asthma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novartis Long-Term Asthma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Merck Long-Term Asthma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Boehringer Ingelheim Long-Term Asthma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AstraZeneca Long-Term Asthma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Roche Long-Term Asthma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Teva Pharmaceutical Long-Term Asthma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Vectura Group Long-Term Asthma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
